ORAGENICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oragenics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Oragenics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.44M, a 16.4% decline year-over-year.
  • Oragenics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$20M, a 92.2% decline year-over-year.
  • Oragenics Inc annual Operating Income (Loss) for 2023 was -$20.9M, a 45% decline from 2022.
  • Oragenics Inc annual Operating Income (Loss) for 2022 was -$14.4M, a 8.56% increase from 2021.
  • Oragenics Inc annual Operating Income (Loss) for 2021 was -$15.8M, a 40.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$20M -$2.44M -$343K -16.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$19.7M -$2.31M +$803K +25.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$20.5M -$2.46M +$445K +15.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.9M -$12.8M -$10.5M -456% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$10.4M -$2.09M +$1.81M +46.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$12.2M -$3.11M +$495K +13.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$12.7M -$2.9M +$1.71M +37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$14.4M -$2.3M +$1.46K +0.06% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$14.4M -$3.91M +$488K +11.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$14.9M -$3.6M +$234K +6.08% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$15.1M -$4.61M +$627K +12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$15.8M -$2.3M +$2.25M +49.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$18M -$4.39M +$114K +2.53% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-04-14
Q2 2021 -$18.1M -$3.84M +$8.51M +68.9% Apr 1, 2021 Jun 30, 2021 10-Q/A 2023-04-14
Q1 2021 -$26.6M -$5.24M -$5.72K -0.11% Jan 1, 2021 Mar 31, 2021 10-Q/A 2023-04-14
Q4 2020 -$26.6M -$4.55M -$891K -24.4% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-29
Q3 2020 -$25.8M -$4.51M -$588K -15% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$25.2M -$12.4M -$7.45M -152% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$17.7M -$5.23M -$1.84M -54.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 -$15.9M -$3.66M -$834K -29.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$15M -$3.92M -$1.16M -41.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$13.9M -$4.9M -$2.62M -115% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$11.3M -$3.39M -$1.27M -60% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$9.99M -$2.82M -$1.41M -100% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$8.58M -$2.76M -$843K -43.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$7.74M -$2.28M -$887K -63.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$6.85M -$2.12M -$134K -6.74% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$6.72M -$1.41M +$1.3M +47.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.01M -$1.92M +$105K +5.19% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$8.12M -$1.4M +$337K +19.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$8.46M -$1.99M +$87K +4.19% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$8.54M -$2.71M -$433K -19.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 -$8.11M -$2.03M -$161K -8.61% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$7.95M -$1.73M +$4.61M +72.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$12.6M -$2.07M -$778K -60% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$11.8M -$2.27M -$1.04M -84.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 -$10.7M -$1.87M -$831K -80.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$9.91M -$6.34M -$4.44M -233% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$5.46M -$1.3M +$353K +21.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$5.82M -$1.23M +$1.84M +60% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$7.66M -$1.03M +$8.29M +88.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$16M -$1.9M +$173K +8.32% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$16.1M -$1.65M +$87.2K +5.02% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$16.2M -$3.07M -$1.09M -54.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$15.1M -$9.33M -$7.23M -345% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 -$7.9M -$2.08M +$4.79M +69.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$12.7M -$1.74M -$257K -17.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$12.4M -$1.99M -$173K -9.51% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$12.3M -$2.1M -$385K -22.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-25
Q2 2012 -$11.9M -$6.87M -$4.56M -198% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$7.31M -$1.48M +$36.5K +2.41% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$7.35M -$1.82M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-26
Q3 2011 -$1.71M +$160K +8.53% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$2.3M -$295K -14.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$1.52M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.87M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.01M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.